Eliminating Lymphatic Filariasis
Identifieur interne : 001120 ( Istex/Checkpoint ); précédent : 001119; suivant : 001121Eliminating Lymphatic Filariasis
Auteurs : Thomas Streit [États-Unis] ; Jack Guy Lafontant [États-Unis]Source :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 2008-06.
Abstract
Among infections closely associated with poverty, lymphatic filariasis (LF) is a study in contrasts. It is both a consequence of and a contributor to poverty. Although rarely fatal, it is recognized as a leading global cause of lifelong disability as well as significant personal, social, and economic burdens coincident with disease. Infection is often considerably more prevalent in communities than the number of cases of overt pathology for which LF is best known (lymphedema, elephantiasis, and hydrocele). With an estimated 120 million to 130 million affected persons in 83 countries and 1.25 billion persons living in areas at risk, in some countries LF may be expanding its range, whereas in others, with economic development, it has disappeared with little if any targeted intervention. The transmission cycle is relatively inefficient, yet an association with pockets of deepest poverty remains tenacious. Thanks to scientific advances in diagnostic tools, and particularly in control strategies focused on large‐scale drug donation and mass drug distribution programs, scientists and policy makers now consider LF eliminable. Together with new approaches for morbidity control, a hopeful tone surrounds a disease problem that as recently as two decades ago could easily have been categorized as among the most neglected of neglected diseases. Continued progress toward global LF elimination will require solutions to potential obstacles in the most challenging—that is, the poorest—endemic settings. This chapter reviews progress toward LF elimination and some of the remaining challenges from a perspective in Haiti, the only least developed country of the Americas.
Url:
DOI: 10.1196/annals.1425.036
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:562F9018AE49C92E9F2DE9A319EAC42B16539AC6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Eliminating Lymphatic Filariasis</title><author><name sortKey="Streit, Thomas" sort="Streit, Thomas" uniqKey="Streit T" first="Thomas" last="Streit">Thomas Streit</name></author><author><name sortKey="Lafontant, Jack Guy" sort="Lafontant, Jack Guy" uniqKey="Lafontant J" first="Jack Guy" last="Lafontant">Jack Guy Lafontant</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:562F9018AE49C92E9F2DE9A319EAC42B16539AC6</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1196/annals.1425.036</idno><idno type="url">https://api.istex.fr/document/562F9018AE49C92E9F2DE9A319EAC42B16539AC6/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002783</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002783</idno><idno type="wicri:Area/Istex/Curation">002783</idno><idno type="wicri:Area/Istex/Checkpoint">001120</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001120</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main"><hi rend="italic">Eliminating Lymphatic Filariasis</hi></title><author><name sortKey="Streit, Thomas" sort="Streit, Thomas" uniqKey="Streit T" first="Thomas" last="Streit">Thomas Streit</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health and Infectious Diseases, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Lafontant, Jack Guy" sort="Lafontant, Jack Guy" uniqKey="Lafontant J" first="Jack Guy" last="Lafontant">Jack Guy Lafontant</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health and Infectious Diseases, Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation><affiliation></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Annals of the New York Academy of Sciences</title><title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title><idno type="ISSN">0077-8923</idno><idno type="eISSN">1749-6632</idno><imprint><biblScope unit="vol">1136</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="53">53</biblScope><biblScope unit="page" to="63">63</biblScope><biblScope unit="page-count">11</biblScope><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2008-06">2008-06</date></imprint><idno type="ISSN">0077-8923</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0077-8923</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Among infections closely associated with poverty, lymphatic filariasis (LF) is a study in contrasts. It is both a consequence of and a contributor to poverty. Although rarely fatal, it is recognized as a leading global cause of lifelong disability as well as significant personal, social, and economic burdens coincident with disease. Infection is often considerably more prevalent in communities than the number of cases of overt pathology for which LF is best known (lymphedema, elephantiasis, and hydrocele). With an estimated 120 million to 130 million affected persons in 83 countries and 1.25 billion persons living in areas at risk, in some countries LF may be expanding its range, whereas in others, with economic development, it has disappeared with little if any targeted intervention. The transmission cycle is relatively inefficient, yet an association with pockets of deepest poverty remains tenacious. Thanks to scientific advances in diagnostic tools, and particularly in control strategies focused on large‐scale drug donation and mass drug distribution programs, scientists and policy makers now consider LF eliminable. Together with new approaches for morbidity control, a hopeful tone surrounds a disease problem that as recently as two decades ago could easily have been categorized as among the most neglected of neglected diseases. Continued progress toward global LF elimination will require solutions to potential obstacles in the most challenging—that is, the poorest—endemic settings. This chapter reviews progress toward LF elimination and some of the remaining challenges from a perspective in Haiti, the only least developed country of the Americas.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Indiana</li></region></list><tree><country name="États-Unis"><region name="Indiana"><name sortKey="Streit, Thomas" sort="Streit, Thomas" uniqKey="Streit T" first="Thomas" last="Streit">Thomas Streit</name></region><name sortKey="Lafontant, Jack Guy" sort="Lafontant, Jack Guy" uniqKey="Lafontant J" first="Jack Guy" last="Lafontant">Jack Guy Lafontant</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001120 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001120 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:562F9018AE49C92E9F2DE9A319EAC42B16539AC6
|texte= Eliminating Lymphatic Filariasis
}}
| This area was generated with Dilib version V0.6.31. |  |